IRF4 expression is inversely correlated with clinical outcome of myeloma (Heintel et al., 2008) and IRF4-dependent modulation of Fas-induced apoptosis governs, in part, myeloma survival (Fanzo et al., 2006). Here, IRF4 is linked to plasma cell myeloma.